Last reviewed · How we verify
Ketamine maintenance
At a glance
| Generic name | Ketamine maintenance |
|---|---|
| Also known as | Ketalar, Calypsol, Ketamin, Ketaminol, Ketanest |
| Sponsor | University of Pennsylvania |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery (PHASE1)
- Effect of Esketamine on Postoperative Sleep in Postmenopausal Women (NA)
- Prospective IR-led Sedation Feasibility (PHASE1, PHASE2)
- Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression (PHASE2)
- Virtual Reality-Based Mindfulness as an Adjunct to Treatment as Usual in Treatment-Resistant Depression (NA)
- Opioid-Free vs Opioid-Based Anesthesia in Bariatric Surgery (NA)
- General Anesthesia Versus Sedation By Dexmedetomidine and Ketamine With Local Infiltration for Percutaneous Transcatheter Closure of Atrial Septal Defect in Pediatric Patients (NA)
- Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |